Efficacy of Tumor-Infiltrating Lymphocytes Combined with IFN-α in Chinese Resected Stage III Malignant Melanoma

Table 1

Clinical characteristics of 77 patients in this study.

	Arm 1 ()	Arm 2 ()	value
Sex
Male	12	29	0.255
Female	15	21
Age (year)
>60	11	21	0.915
≤60	16	29
KPS
≥80	22	45	0.289
<80	5	5
Primary tumor site
Mucosa type	4	15	0.140
No-mucosa type	23	35
R-CIK
Yes	22	45	0.289
No	5	5
Treatment after metastasis
Surgical	8	10	—
Immunotherapy	27	45	—
Chemotherapy	5	10	—
Radiotherapy	3	6	—
Any 2 or more	16	35	—
Any 3 or more	3	8	0.912

In Arm 1, mucosa type patients include 3 patients with nasal cavity mucosa melanoma and one patient with mouth cavity melanoma. No-mucosa type patients include 12 patients with acral lentiginous melanoma, 7 patients with nodular melanoma, and 4 patients with superficial spreading melanoma. In Arm 2, mucosa type patients include 5 patients with rectal mucosa melanoma, 6 patients with nasal cavity mucosa melanoma, 2 patients with mouth cavity melanoma, one patient with penis mucosa melanoma, and one patient with vaginal mucosa melanoma. No-mucosa type patients include 14 patients with acral lentiginous melanoma, 11 patients with nodular melanoma, and 10 patients with superficial spreading melanoma.